Related Experiment Video

Updated: Feb 2, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

745

Factors associated with poor medication compliance in hypertensive patients

Khadija Mzoughi, Ihsen Zairi, Aymen Jemai

    La Tunisie Medicale
    |November 16, 2018
    PubMed

    Insights

    Poor medication adherence in hypertension is common, affecting 20.5% of patients. Key factors include multiple specialist physicians and lack of patient information on hypertension risks. Improving adherence requires better patient education and coordinated care.

    Area of Science:

    • Cardiology
    • Public Health
    • Pharmacology

    Background:

    • Hypertension significantly contributes to cardiovascular disease burden.
    • Despite treatments, many patients do not reach blood pressure targets.
    • Poor medication adherence is a primary reason for treatment failure.

    Purpose of the Study:

    • To identify factors associated with poor medication adherence in hypertensive patients.
    • To understand the barriers to successful hypertension management.

    Main Methods:

    • A descriptive prospective study was conducted with 200 hypertensive patients.
    • Data collected via semi-directed interviews using the Girerd medication adherence questionnaire.
    • Patient demographics, risk factors, and adherence were assessed.

    Main Results:

    • The prevalence of poor medication adherence was 20.5%.
    • Independent factors linked to poor adherence included having more than one specialist physician (OR=3.444) and lacking information on hypertension (OR=4.345).
    • Predominant risk factors were dyslipidemia (45%), smoking (36.5%), and diabetes (25.5%).

    Conclusions:

    • Improving medication adherence necessitates enhanced patient education regarding hypertension and its risks.
    • Harmonizing care among treating physicians is crucial for better patient outcomes.
    • Targeted interventions should address physician coordination and patient information dissemination.
    Abstract

    More Related Videos

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

    Published on: April 23, 2021

    3.5K
    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor05:54

    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

    Published on: December 13, 2017

    14.8K

    Related Concept Videos

    Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

    Factors Affecting Protein-Drug Binding: Patient-Related Factors

    Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
    Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
    325
    Inhaled Medications01:23

    Inhaled Medications

    Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
    801
    Hypertension I: Introduction01:28

    Hypertension I: Introduction

    Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
    879
    Hypertension II: Pathophysiology01:29

    Hypertension II: Pathophysiology

    Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
    944
    Hypertension V: Nursing Management01:23

    Hypertension V: Nursing Management

    The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
    433
    Transcription Factors02:16

    Transcription Factors

    Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
    82.7K